Muscle-invasive bladder cancer: Evaluating treatment and survival in the National Cancer Data Base

BJU International

Volumn 114, Issue 5, 2014, Pages 719-726

  Smith, Angela B ^a,b   Deal, Allison M ^b,c   Woods, Michael E ^a,b   Wallen, Eric M ^a,b   Pruthi, Raj S ^a,b   Chen, Ronald C ^a,b   Milowsky, Matthew I ^a,b   Nielsen, Matthew E ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

Author keywords

bladder cancer; bladder sparing therapy; radical cystectomy; treatment outcome; urinary bladder neoplasms

Indexed keywords

AGED; ARTICLE; BLADDER SURGERY; BLADDER TUMOR TRANSURETHRAL RESECTION; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CANCER THERAPY; CHARLSON COMORBIDITY INDEX; CHEMORADIOTHERAPY; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; SCORING SYSTEM; CONSERVATIVE TREATMENT; FACTUAL DATABASE; MIDDLE AGED; MORTALITY; PROCEDURES; REGISTER; UNITED STATES; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CYSTECTOMY; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN SPARING TREATMENTS; REGISTRIES; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 84912531296     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12601     Document Type: Article

References (20)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30
2. Clark PE, Spiess PE, Agarwal N, et al. NCCN Guidelines Version 1.2013: Bladder Cancer. 2013. Available at: http://www.nccn.org/professionals/physician-gls/pdf/bladder.pdf. Accessed 14 May 2013
3. Solsona E, Iborra I, Collado A, Rubio-Briones J, Casanova J, Calatrava A,. Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer. J Urol 2010; 184: 475-480
4. Schrag D, Mitra N, Xu F, et al. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population. Urology 2005; 65: 1118-1125
5. Shipley WU, Kaufman DS, Zehr E, et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 2002; 60: 62-67; discussion 67-8
6. Gore JL, Litwin MS, Lai J, et al. Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 2010; 102: 802-811
7. Fedeli U, Fedewa SA, Ward EM,. Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J Urol 2011; 185: 72-78
8. Gray PJ, Fedewa SA, Shipley WU, et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur Urol 2013; 63: 823-829
9. National Cancer Data Base. 2013. American College of Surgeons Cancer Programs National Cancer Data Base. Available at: http://www.facs.org/cancer/ncdb/index.html. Accessed 14 May 2013
10. Commission on Cancer of the American College of Surgeons. Facility Oncology Registry Data Standards (FORDS): Revised for 2013. 2012
11. United States Department of Agriculture Economic Research Service. Rural-Urban Continuum Codes. 2013. Available at: http://www.ers.usda.gov/data-products/rural-urban-continuum-codes/documentation.aspx. Accessed 14 May 2013
12. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619
13. Chan R, Morrill S, Freeman D Jr, Colman M, Zwischenberger J,. Bi-modality (chemo-radiation) versus tri-modality (chemo-radiation followed by surgery) treatment for carcinoma of the esophagus. Dis Esophagus 2001; 14: 202-207
14. Efstathiou JA, Spiegel DY, Shipley WU, et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol 2012; 61: 705-711
15. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-675
16. Feifer A, Taylor JM, Shouery M, et al. Multi-institutional quality-of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder: phase I. J Clin Oncol 2011; 29: abstract 240
17. Hollenbeck BK, Taub DA, Dunn RL, Wei JT,. Quality of care: partial cystectomy for bladder cancer-a case of inappropriate use? J Urol 2005; 174: 1050-1054; discussion 1054
18. Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Lee CT, Birkmeyer JD,. Racial differences in treatment and outcomes among patients with early stage bladder cancer. Cancer 2010; 116: 50-56
19. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS, Urologic Diseases in America P. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer 2009; 115: 988-996
20. Khochikar M,. Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival. BJU Int 2011; 108: E288-289